| Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation GJ Freeman, AJ Long, Y Iwai, K Bourque, T Chernova, H Nishimura, ... The Journal of experimental medicine 192 (7), 1027-1034, 2000 | 6232 | 2000 |
| PD-L2 is a second ligand for PD-1 and inhibits T cell activation Y Latchman, CR Wood, T Chernova, D Chaudhary, M Borde, I Chernova, ... Nature immunology 2 (3), 261-268, 2001 | 3657 | 2001 |
| Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade Y Iwai, M Ishida, Y Tanaka, T Okazaki, T Honjo, N Minato Proceedings of the National Academy of Sciences 99 (19), 12293-12297, 2002 | 3584 | 2002 |
| Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice H Nishimura, T Okazaki, Y Tanaka, K Nakatani, M Hara, A Matsumori, ... Science 291 (5502), 319-322, 2001 | 2271 | 2001 |
| Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer J Hamanishi, M Mandai, M Iwasaki, T Okazaki, Y Tanaka, K Yamaguchi, ... Proceedings of the National Academy of Sciences 104 (9), 3360-3365, 2007 | 1847 | 2007 |
| PD-1 and PD-1 ligands: from discovery to clinical application T Okazaki, T Honjo International immunology 19 (7), 813-824, 2007 | 1636 | 2007 |
| PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine T Okazaki, A Maeda, H Nishimura, T Kurosaki, T Honjo Proceedings of the National Academy of Sciences 98 (24), 13866-13871, 2001 | 1084 | 2001 |
| A rheostat for immune responses: the unique properties of PD-1 and their advantages for clinical application T Okazaki, S Chikuma, Y Iwai, S Fagarasan, T Honjo Nature immunology 14 (12), 1212-1218, 2013 | 1008 | 2013 |
| The PD-1–PD-L pathway in immunological tolerance T Okazaki, T Honjo Trends in immunology 27 (4), 195-201, 2006 | 935 | 2006 |
| Tumor cell expression of programmed cell death‐1 ligand 1 is a prognostic factor for malignant melanoma R Hino, K Kabashima, YU Kato, H Yagi, M Nakamura, T Honjo, T Okazaki, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2010 | 844 | 2010 |
| Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice T Okazaki, Y Tanaka, R Nishio, T Mitsuiye, A Mizoguchi, J Wang, M Ishida, ... Nature medicine 9 (12), 1477-1483, 2003 | 770 | 2003 |
| Human obese gene expression: adipocyte-specific expression and regional differences in the adipose tissue H Masuzaki, Y Ogawa, N Isse, N Satoh, T Okazaki, M Shigemoto, K Mori, ... Diabetes 44 (7), 855-858, 1995 | 695 | 1995 |
| Resting dendritic cells induce peripheral CD8+ T cell tolerance through PD-1 and CTLA-4 HC Probst, K McCoy, T Okazaki, T Honjo, M van den Broek Nature immunology 6 (3), 280-286, 2005 | 677 | 2005 |
| Establishment of NOD-Pdcd1-/-mice as an efficient animal model of type I diabetes J Wang, T Yoshida, F Nakaki, H Hiai, T Okazaki, T Honjo Proceedings of the National Academy of Sciences 102 (33), 11823-11828, 2005 | 560 | 2005 |
| PD-1 inhibits antiviral immunity at the effector phase in the liver Y Iwai, S Terawaki, M Ikegawa, T Okazaki, T Honjo Journal of Experimental Medicine 198 (1), 39-50, 2003 | 547 | 2003 |
| The PD-1/PD-L1 complex resembles the antigen-binding Fv domains of antibodies and T cell receptors DY Lin, Y Tanaka, M Iwasaki, AG Gittis, HP Su, B Mikami, T Okazaki, ... Proceedings of the National Academy of Sciences 105 (8), 3011-3016, 2008 | 524 | 2008 |
| Role of PD-1 in regulating T-cell immunity HT Jin, R Ahmed, T Okazaki Negative co-receptors and ligands, 17-37, 2011 | 413 | 2011 |
| Structural organization and chromosomal assignment of the human obese gene N Isse, Y Ogawa, N Tamura, H Masuzaki, K Mori, T Okazaki, N Satoh, ... Journal of Biological Chemistry 270 (46), 27728-27733, 1995 | 409 | 1995 |
| Differential expression of PD-L1 and PD-L2, ligands for an inhibitory receptor PD-1, in the cells of lymphohematopoietic tissues M Ishida, Y Iwai, Y Tanaka, T Okazaki, GJ Freeman, N Minato, T Honjo Immunology letters 84 (1), 57-62, 2002 | 385 | 2002 |
| IFN-α directly promotes programmed cell death-1 transcription and limits the duration of T cell-mediated immunity S Terawaki, S Chikuma, S Shibayama, T Hayashi, T Yoshida, T Okazaki, ... The Journal of Immunology 186 (5), 2772-2779, 2011 | 378 | 2011 |
